Detalhe da pesquisa
1.
Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up.
J Am Pharm Assoc (2003)
; 59(2): 178-186, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655090